538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine
Pediatric Research(2010)
摘要
Aims: The efficacies of live attenuated influenza vaccine (LAIV) and trivalent inactivated influenza vaccine (TIV) have been evaluated in children and adults in multiple studies; however, vaccine impact on illness severity has not been examined. This analysis compared illness severity among LAIV and TIV recipients who developed influenza illness using data from existing randomized studies. LAIV is approved for eligible individuals 2-49 years of age in the United States, Israel, Hong Kong, Macau, and South Korea. Methods: Three studies in children, one wild-type challenge study in adults 18-45 years, and one study in adults ≥60 years compared LAIV and TIV efficacy and collected symptom duration and severity. Results: In 2 studies of children < 6 years, a higher proportion of LAIV versus TIV breakthroughs were afebrile: 22% vs. 12% (P=0.001) and 28% vs. 5% (P=0.005). In one study, LAIV breakthroughs missed 1.6 (95% CI: 2.9, 0.2) fewer days of school/daycare and had less antibiotic use (17% LAIV vs. 33% TIV, P=0.11). No differences were seen in a study of children 6-17 years. In the adult challenge study, LAIV vaccinees tended to have lower mean symptom scores versus TIV and placebo recipients (2.7, 5.7, 9.2, respectively, P=NS except LAIV vs placebo). In the older adult study, LAIV breakthroughs had less feverishness (14% LAIV vs 46% TIV, P=0.05). Conclusions: Among younger children, LAIV recipients who develop breakthrough influenza have less severe illness than TIV recipients. The same may be true among adults; however, more research is needed. Sponsored by MedImmune.
更多查看译文
关键词
pediatric, allergy, immunology, cardiology, endocrinology, epidemiology, public health, fetus, pregnancy, gasteroenterology, genetics, hematology, oncology, infectious disease, neonatology, nephrology, neurology, nutrition, pulmonology, rheumatology , Pediatric Research, PR, Pediatr Res, nature journals, nature publishing group
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络